To facilitate discrimination between the closely related enteropathogens Campylobacter jejuni and C. coli, unique differences in antigenic surface structure were examined. A genomic library of C. jejuni 81116 was constructed in plasmid pBluescriptIISK ؊ and expressed in Escherichia coli K-12. Rabbit hyperimmune serum raised against C. jejuni ATCC 29428 recognized a clone expressing a C. jejuni 24-kDa membrane-associated protein. Antiserum raised against sonicated recombinant E. coli expressing the 24-kDa protein reacted with C. jejuni, whereas C. coli did not react specifically. Determination of the nucleotide sequence of the DNA insert of this recombinant plasmid revealed an open reading frame encoding 214 amino acids; the gene was designated mapA; and its gene product was designated MAPA. The 18 N-terminal amino acid residues constitute a signal sequence characteristic of prokaryotic membrane lipoproteins. In a dot blot hybridization assay with a mapA probe, 120 clinical isolates of C. jejuni were unequivocally discriminated from 126 other campylobacters, including 34 C. coli isolates. A PCR test based on the mapA sequence was developed for identification of C. jejuni. A PCR product was obtained with all of the clinical isolates of C. jejuni tested from human, dog, cat, bovine calf, and chicken sources. Recombinant MAPA with an added C-terminal six-histidine tail was affinity purified and used to immunize rabbits. The rabbit anti-MAPA serum specifically recognized the protein in whole cells of C. jejuni on Western blots (immunoblots). The MAPA protein was present in all of the C. jejuni strains tested and was absent in C. coli and related campylobacters.
Thermophilic Campylobacter species, particularly Campylobacter jejuni and C. coli, are among the most frequently isolated bacteria that cause diarrheal disease in humans (25) . The organisms can occur, often as commensals, in cattle, pigs, sheep, poultry, various domestic animals, birds, apes, rodents, and even insects (3, 15, 28) . C. coli is often isolated from feces of pigs, and both enteropathogens are considered to share many clinical and epidemiological characteristics. Detailed knowledge is dependent on accurate differentiation between C. jejuni and C. coli. Most C. jejuni infections are associated with consumption of poultry, raw milk, or untreated surface water and contact with pets (25) .
Isolation of campylobacters from clinical samples requires long incubation times with special growth conditions (9) . Discrimination between the closely related species C. jejuni and C. coli is based only on the hippurate hydrolysis test (2) . However, this phenotypic test does not always distinguish between C. jejuni and C. coli. A minority of isolates do not conform to the pattern exhibited by the majority (11, 18, 26) . To complement the hippurate hydrolysis test and improve discrimination between C. jejuni and C. coli, a number of new genetic or phenotypic identification and discriminatory assays have recently been developed by many investigators.
Genetic identification methods exploit the species specificity of cloned arbitrary DNA sequences (7, 8, 16) , specific PCR amplification of defined DNA fragments of 16S or 23S rRNA genes and their intervening sequences (6, 7, 27) , or amplification of parts of regions of the flagellin genes (17) . Immunological identification tests, on the other hand, have been used for many groups of bacteria, including the enteropathogens Shigella flexneri, Vibrio cholerae, salmonellae, and Escherichia coli (4) . The use of species-specific antibodies raised against surface antigens for identification of C. jejuni and C. coli has also been reported (10) . The method requires preparation of partially purified membrane protein, immunization of rabbits, and absorption of the resulting antisera with cross-reacting Campylobacter species. A simplification of serological identification of campylobacters based on recombinant species-specific antigens would therefore be very helpful. In the present report, we describe the cloning and characterization of a species-specific 24-kDa membrane-associated protein of C. jejuni 81116, named MAPA for membrane-associated protein A. Rabbit antisera raised against the C. jejuni MAPA protein did not cross-react with proteins of C. coli or other related bacteria. The mapA gene has been found to be useful for genetic identification of C. jejuni by PCR or hybridization, and the MAPA protein is also a good candidate for serological discrimination between C. jejuni and C. coli.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The bacterial strains and type strains used in this study are listed in Table 1 . Campylobacter, Bacteroides, Arcobacter, and Helicobacter spp. were cultured on Columbia agar supplemented with 5% sheep blood (bioMérieux, Geneva, Switzerland) in a microaerophilic atmosphere of 6% O 2 , 7% CO 2 , and 7% H 2 in N 2 at 37ЊC for 20 h. For all gene cloning and expression experiments, E. coli Sure (Stratagene, La Jolla, Calif.) or E. coli BL21 (DE3) (24; gift from Stan Tabor, Harvard Medical School, Boston, Mass.) was used. Plasmids pBluescriptIISK Ϫ (Stratagene), pT7-7 (24; gift from Stan Tabor), and pQE16 (Qiagen Inc.) were used for cloning of genomic DNA fragments of C. jejuni. Genomic DNA of reference strain C. jejuni 81116 was partially digested with HindIII. Selected DNA fragments in the size range of 1 to 7 kb were isolated from agarose gels and ligated into the HindIII site of pBluescriptIISK Ϫ . The ligation mixture was transformed into E. coli Sure cells by the calcium chloride procedure (22) . For screening of recombinant E. coli colonies, growth was transferred to nitrocellulose filters (Schleicher & Schuell, Dassel, Germany) by replica blotting. The filters were then placed on new Luria-Bertani agar plates supplemented with 25 mg of ampicillin per ml, 25 mg of tetracycline per ml, and 166 M isopropyl-␤-D-thiogalactopyranoside (IPTG; 22) and incubated at 37ЊC. After 4 h, the recombinants were lysed in situ by soaking the filters in lysis buffer (100 mM Tris-HCl [pH 7.8], 150 mM NaCl, 5 mM MgCl 2 , 1.5% bovine serum albumin, 50 g of lysozyme per ml) for 4 h and probed with hyperimmune serum raised against live C. jejuni ATCC 29428 as previously described (1) .
Nucleic acid methods. Nucleic acids were extracted by a slightly modified guanidium thiocyanate microprocedure (19) . Instead of ammonium acetate, 0.1 volume of a 3 M NaCl solution was added to promote precipitation of DNA. Nucleic acid concentrations were estimated by using agarose gels with lambda DNA as the reference. A dot blot DNA hybridization assay with lysates of campylobacters was performed as described previously (5) . To isolate the gene probe for the dot blot and Southern hybridizations, recombinant plasmid pIVB2 was digested with restriction enzymes EcoRI and HindIII in accordance with the instructions of the manufacturer (Boehringer, Mannheim, Germany). The DNA was separated on a 0.7% agarose gel, and the gene probe was eluted by a standard protocol (29) and labeled with [ 32 P]dCTP (300 Ci/mmol; Amersham plc) by using a random primed DNA labeling kit (Boehringer). Hybridizations were carried out for 16 h at 37ЊC in 5ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M trisodium citrate [pH 7.0])-50% formamide-5% polyethylene glycol 6000-0.5% sodium dodecyl sulfate (SDS)-100 g of denatured and sonicated salmon sperm DNA per ml. Filters were washed in 0.1ϫ SSC-0.1% SDS at room temperature for 30 min. Autoradiography was carried out for 2 days on Fuji RX films with an intensifying screen.
DNA sequencing and analysis. With EcoRI and SpeI, the insert of pIVB2 was cut into three fragments similar in size. The fragments were subcloned into pBluescriptIISK Ϫ , resulting in pIVB3, pIVB4, and pIVB5, as shown in Fig. 1B , and used for DNA sequence determination (Fig. 1B) . Sequence analysis was accomplished by the dideoxy-chain termination method of Sanger et al. (23) with [ Kingdom) and T7 DNA polymerase with the Sequenase sequencing kit (United States Biochemicals, Cleveland, Ohio). Standard oligonucleotide primers T3 and T7 (Stratagene) were used for sequencing. The DNA sequences were assembled and analyzed by using the PC-Gene DNA and protein analysis programs (IntelliGenetics Inc., University of Geneva, Geneva, Switzerland).
PCR. PCR analysis was performed with a thermal cycler from Perkin ElmerCetus (Norwalk, Conn.). A 0.01-g sample of genomic bacterial DNA was added to 100 l of a PCR mixture (10 mM Tris-HCl [pH 8.3], 1.5 mM magnesium chloride, 50 mM potassium chloride, 0.005% Tween 20, 0.005% Nonidet P-40), with each deoxynucleoside triphosphate at 170 M and each oligodeoxyribonucleotide primer at 0.25 M. Finally, 2.5 U of Taq DNA polymerase (Boehringer) was added. The mixture was covered with 2 drops of mineral oil, and samples were subjected to 35 cycles of amplification consisting of denaturation at 94ЊC for 1 min, primer annealing at 55ЊC for 1 min, and chain extension at 74ЊC for 1 min. An additional extension step at 74ЊC for 5 min was performed at the end of the reaction. The binding sites of oligodeoxyribonucleotides (Microsynth) CJAG48-1L (5Ј-cgcggatccATGTTTAAAAAATTTTTG-3Ј) and CJAG48-1R (5Ј-cgcggatccAAGTTCAGAGATTAAACTAG-3Ј) are given in 29428 cells was produced with bacteria grown on sheep blood agar at 37ЊC for 36 h. The cells were harvested in 0.9% NaCl to the density of a McFarland no. 1 turbidity standard, and rabbits were immunized five times intravenously at intervals of 2 days. The first immunization was carried out with formalinized cells; for booster injections, live C. jejuni cells were used. Titers of antisera were determined by slide agglutination of live cells, and the rabbits were bled by heart puncture. To produce rabbit anti-MAPA serum, recombinant MAPA modified with a six-His tail (MAPA-6ϫHis) was purified by Ni 2ϩ chelate affinity chromatography. To obtain recombinant MAPA-6XHis, the mapA gene amplified by PCR was digested with BamHI and the fragment was ligated into the cloning site of pQE16 cut with BamHI and BglII. By this step, a tail of six consecutive triplets encoding histidine was positioned in frame immediately downstream of the BglII restriction enzyme site. The gene including the six His codons was then recovered from pQE16 by digestion with BamHI and HindIII. This fragment was ligated into expression vector pT7-7 to achieve a high level of expression in E. coli BL21 (DE3). The MAPA-6ϫHis protein accumulated in the insoluble fraction of cell proteins and was purified by Ni 2ϩ chelate affinity chromatography (Qiagen Inc.) in the presence of 6 M guanidine hydrochloride. The MAPA-6ϫHis fractions were pooled and repurified by preparative SDS-polyacrylamide gel electrophoresis (13) , and the recombinant protein was electroeluted from the gel. Rabbits were immunized subcutaneously with 150 g of the purified MAPA protein mixed 1:1 with complete Freund adjuvant (Difco Laboratories, Detroit, Mich.). A booster dose containing an equal quantity of MAPA-6ϫHis in complete Freund adjuvant was injected after 4 weeks. The serum was collected 10 days after the booster injection. Mouse sera were produced against recombinant bacteria grown in Luria-Bertani broth and induced by addition of 0.5 mM IPTG. Approximately 50 mg of pelleted cells were suspended in phosphate-buffered saline, sonicated, and mixed 1:1 with complete Freund adjuvant. Mice were immunized subcutaneously with 0.2 ml of the suspension.
Nucleotide sequence accession number. The nucleotide sequence reported here has been submitted to GenBank and assigned accession number X80135.
RESULTS
Five recombinant E. coli clones, carrying HindIII inserts of genomic DNA of C. jejuni 81116 in pBluescriptIISK Ϫ , expressed proteins recognized by hyperimmune serum against C. jejuni ATCC 29428. All five clones were cultured in liquid medium, and their proteins were analyzed by SDS-polyacrylamide gel electrophoresis and immunoblotting with the same serum. Two of the recombinant E. coli clones expressed a 15-kDa protein, one clone expressed a 24-kDa protein, and the two remaining clones each expressed a 30-kDa protein recognized by the rabbit anti-C. jejuni serum. For further investigations, mouse antisera were produced against each of the recombinants. Antisera raised against all of the 15-or 30-kDa protein-expressing clones recognized proteins similar in size in all of the thermophilic campylobacters tested. The mouse serum raised against the recombinant clone expressing the 24-kDa antigen recognized a 22-kDa protein together with a somewhat weaker band at 20 kDa in C. jejuni, and no reaction was observed with other Campylobacter species. We therefore focused our interest on this recombinant E. coli clone carrying a plasmid, designated pIVB2, with a 915-bp HindIII insert of C. jejuni 81116 genomic DNA.
The nucleotide sequence of the entire HindIII fragment cloned in pIVB2 is shown in Fig. 1A . The insert is 915 bp long and contains two open reading frames (ORF), which are shown as boxes in Fig. 1B . One ORF begins at position 179 and is 642 bp long. It is preceded by a putative ribosome binding site and can encode a 214-amino-acid protein with a molecular mass of 24.0 kDa. Analysis of the deduced amino acid sequence revealed that the N terminus contains a signal sequence with a putative signal peptidase II cleavage site cysteine residue (20) and a sorting signal alanine residue (30) . The gene product may be posttranslationally processed to a 197-aminoacid peptide with a molecular mass of 22.0 kDa. We designated the gene mapA (for membrane-associated protein A) and the corresponding protein, MAPA. Computation of the amino acid sequence of protein MAPA performed at the National Center for Biotechnology Information with the BLAST program revealed no homology to any known proteins. Upstream of mapA, the end of a possible ORF containing 80 nucleotides of the coding region of a gene was found. This partial ORF showed homology to the end of a lepA gene of E. coli over its entire length. The amino acid sequence homology with lepA genes of E. coli and Salmonella typhimurium was 84%. No other significant ORF was found in either direction.
Southern blots of the strains listed in Table 1 , including all of the type strains of the thermophilic Campylobacter group, as well as type strains and reference strains of closely related species and genera, were hybridized with subclones pIVB3, pIVB4, and pIVB5. All three probes hybridized strongly with the same conserved 915-bp HindIII fragment in all of the strains of C. jejuni tested (Fig. 2) . A weak hybridization signal was observed in C. coli with pIVB3, indicating that genes homologous to lepA are probably also present in C. coli. To further corroborate the specificity of mapA for C. jejuni, a mapA probe was used in a colony blot hybridization assay. The probe consisted of the labeled EcoRI-HindIII fragment of pIVB2, which includes most of the coding part of mapA, as well as 91 bp of the downstream flanking sequence (Fig. 1B) . Except for C. jejuni, no Campylobacter strains or related organisms reacted with the probe (results not shown). To further examine the sensitivity and specificity of the mapA probe, 246 fresh clinical isolates were analyzed and the results were compared with identification obtained by total genomic DNA hybridization. All 120 isolates of C. jejuni tested showed positive hybridization with the mapA probe, whereas none of 126 other Campylobacter, Arcobacter, and Helicobacter species tested (34 C. coli, 63 C. upsaliensis, 8 C. helveticus, 3 C. concisus, 3 Arcobacter butzleri, 4 Helicobacter canis, 7 H. cinaedi-like, and 4 H. pullorum strains) gave a positive result (data not shown). Thus, both the sensitivity and specificity of the assay were 100%. A mapA-specific PCR was developed for identification of C. jejuni by using oligonucleotides CJAG48-1L and CJAG48-1R, located at both ends of mapA. Genomic DNAs of the type and reference strains listed in Table 1 were subjected to PCR. The result of the C. jejuni-specific amplification of the mapA gene 
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on January 13, 2018 by guest http://jcm.asm.org/ is shown in Fig. 2 . To test the sensitivity of this detection assay, 10-fold dilutions containing 50 ng to 5 fg of genomic DNA of C. jejuni 81116 were used as templates for PCR. The 5-fg amount gave an amplification reaction with a product sufficient for visualization on agarose gels stained with ethidium bromide. Template DNA for PCR was also obtained by boiling a cell suspension. Tenfold dilutions of suspensions of C. jejuni 81116, containing 2.6 ϫ 10 7 to 26 cells were made in water. The suspensions were boiled for 5 min prior to use of the supernatant as a PCR template. Amplification products were reliably obtained from 26 C. jejuni cells. In addition, we were able to amplify mapA in 41 strains of C. jejuni isolated from sources as different as humans, dogs, cats, bovine calves, and chickens. All amplification products showed identical restriction patterns with restriction enzymes EcoRI and AluI (data not shown).
Finally, serological identification of C. jejuni was attempted with monospecific, polyclonal anti-MAPA hyperimmune serum. For this purpose, we genetically modified the mapA gene to obtain a MAPA-6ϫHis fusion protein (see Materials and Methods) which was purified by Ni 2ϩ chelate affinity chromatography. Sera of rabbits immunized with the recombinant MAPA-6ϫHis protein recognized the recombinant, nonmodified MAPA protein in E. coli at a dilution of 1:8,000 as a 24-kDa protein band (Fig. 3) . C. jejuni cells were weakly labeled by anti-MAPA antibodies coupled to fluorescein isothiocyanate. However, the anti-MAPA sera strongly reacted in immunoblots with a 22-kDa protein of C. jejuni. A weaker band reacting at 20 kDa was also observed in C. jejuni, whereas some strains of C. coli showed a very weak reaction (Fig. 3) . The remaining bacterial species included in Table 1 showed no reaction (results not shown).
DISCUSSION
Discrimination between the closely related human enteropathogens C. jejuni and C. coli (26) is based solely on one phenotypic characteristic, hippurate hydrolysis (2, 18) . This test is not entirely reliable because hippurate-negative C. jejuni can be encountered, which leads to misidentifications (11, 18) . Because the precise differentiation between C. jejuni and C. coli is of epidemiological significance, additional methods are needed. Therefore, several investigators have developed alternative means of identification and many of the methods are based on genetic approaches (6-8, 12, 17, 27) . However, most of the procedures involved are complex and require specialized reagents and equipment. Therefore, genetic methods are confined to specialized research establishments; for routine use in clinical laboratories, they would have to be more rapid and involve fewer steps (12) .
On the other hand, serological means of bacterial identification have been traditionally used for many groups of bacteria (4) and have been suggested to differentiate between C. jejuni and C. coli (10) . We therefore cloned and expressed in E. coli an antigen which is specific for C. jejuni from a gene bank made with genomic DNA of strain 81116.
Among several clones expressing C. jejuni antigens, one, mediating the expression of a 24-kDa protein designated MAPA, was chosen since mouse sera raised to MAPA specifically reacted with C. jejuni. The deduced protein sequence of MAPA showed a consensus with prokaryote signal sequence peptidase II recognition sequences for the N-terminal 18 amino acids. The highly conserved amino acid cysteine at position 18 (Fig. 1A) is known to be the cleavage site for the peptidase (20) . This suggests that MAPA is posttranslationally modified by signal cleavage into a 22-kDa peptide. The signal sequence also indicates that MAPA probably belongs to the group of lipoproteins which contains fatty acid residues linked to the glyceryl cysteine which provides the site for cleavage. The amino acid adjacent to the signal peptidase cleavage site is known to be the sorting signal for the mature protein, i.e., that which determines its localization to the inner or outer membrane. This amino acid is alanine for MAPA, suggesting that MAPA is an inner membrane protein (30) . Indirect experimental evidence of the localization of the mature MAPA protein in the inner membrane of C. jejuni was as follows: (i) MAPA was absent in outer membrane preparations of C. jejuni, (ii) C. jejuni was not agglutinated by anti-MAPA sera, and (iii) the surface of C. jejuni was not labeled by rabbit anti-MAPA antibodies conjugated to fluorescein isothiocyanate. On immunoblots, anti-MAPA antibodies reacted with a 24-kDa protein in the recombinant E. coli strain containing pIVB2 and with 22-and 20-kDa proteins in all of the C. jejuni strains tested (Fig. 3) . This indicates that recombinant MAPA expressed in E. coli remains unprocessed, while the 22-kDa protein in C. jejuni would represent the processed MAPA protein after cleavage of the signal sequence. Available evidence does not give clues as to the nature of the weakly reacting band at 20 kDa, which may indicate further processing or degradation. A protein band slightly smaller in size than 22 kDa giving very weak serological cross-reactions in some strains of C. coli may indicate the presence of a distantly related protein in this species.
The specificity of the mapA gene for C. jejuni was shown by colony blot hybridization. All 120 isolates of C. jejuni tested hybridized with a mapA probe, whereas none of 126 other Campylobacter, Arcobacter, and Helicobacter isolates, including 34 C. coli isolates, did. In addition, the mapA gene was amplified by PCR in 41 clinical C. jejuni isolates originating from sources as different as humans, dogs, cats, bovine calves, and chickens. The amplification product showed no restriction fragment polymorphisms when digested with multiple restriction enzymes, further indicating that the gene is well conserved among isolates of C. jejuni. Thus, a simple PCR amplification allows specific identification of C. jejuni on the basis of mapA sequences.
Our sequence data on C. jejuni show the end of an ORF upstream of the mapA gene that shares significant homology with the 3Ј end of the E. coli lepA gene. In E. coli, lepA encodes a membrane-associated GTP binding protein (14, 21) . Se- quences hybridizing with pIVB3, which carries the lepA-homologous sequences of C. jejuni, were also found among other campylobacters, indicating that this function is widespread among phylogenetically distant gram-negative bacteria. Whether the lepA homolog and mapA form part of an operon in C. jejuni cannot be ascertained.
The high degree of conservation of the mapA gene in C. jejuni and its apparent specificity for the species make MAPA a good candidate for serological identification of C. jejuni. Hyperimmune rabbit sera raised against purified recombinant MAPA-6ϫHis were shown to be able to differentiate C. jejuni from a broad variety of other campylobacters and related organisms, including C. coli. The use of a defined antigen, which has been cloned and expressed, offers many advantages over sera raised against whole campylobacter cells for the immunodiagnosis of C. jejuni. The main advantage over existing methods is the specificity and reproducibility of reagents, as well as the fact that lengthy and cumbersome absorptions are not needed (10) . In summary, we have shown that specific identification of C. jejuni on the basis of mapA can be achieved both by PCR and serologically.
